Clinical trials: Anlotinib
Soft Tissue Sarcoma, Doxorubicin
Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma
Exploring the Efficacy and Safety of Anlotinib Combined with Doxorubicin Monotherapy and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma
- Conditions
- Soft Tissue Sarcoma, Doxorubicin, Radiotherapy
- Trial name
- NCT06506838
- Testing
- Anlotinib
- Where
- 2 sites in China
- Volunteers
- 39 people
- Sponsor
- Guangdong Provincial People's Hospital
Sarcoma
Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children
The purpose is to observe and evaluate the safety and effectiveness of anlotinib in children with progressive, recurrent, and refractory sarcoma. Pharmacokinetics was also detected.
- Trial name
- NCT04659733
- Testing
- Anlotinib hydrochloride
- Volunteers
- 36 people
- Sponsor
- Yizhuo Zhang
ICC
Treatment of Advanced Intrahepatic Cholangiocarcinoma
The purpose of this study is to evaluate the efficacy and safety of Levamisole Hcl in the treatment of patients with advanced intrahepatic cholangiocarcinoma.
- Trial name
- TAICC (NCT03940378)
- Testing
- Levamisole Hydrochloride, Anlotinib Hydrochloride Capsules
- Where
- China
- Volunteers
- 152 people
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors
A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors
AK105 is a humanized monoclonal antibody that specially binds to PD-1. Anlotinib is a small molecule tyrosine kinase inhibitor. Based on the mechanism study, tumor vascular abnormalities promote tissue hypoxia and increase lactic…
- Trial name
- NCT04207463
- Testing
- AK105, Anlotinib
- Where
- 7 sites in China
- Volunteers
- 150 people
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
NSCLC
Efficacy and Safety of Induction Benmelstobart Plus Anlotinib and Chemotherapy Followed by Concurrent Chemoradiotherapy and Benmelstobart Maintenance Versus Concurrent Chemoradiotherapy Followed by Benmelstobart Maintenance in Patients With Unresectable Stage III NSCLC
The goal of this clinical trial is to compare the efficacy and safety of induction Benmelstobart plus Anlotinib and chemotherapy followed by concurrent chemoradiotherapy (CCRT) and subsequent Benmelstobart maintenance versus CCRT…
- Trial name
- NCT07643350
- Testing
- Benmelstobart, benmelstobart combined with chemotherapy and anlotinib
- Where
- China
- Volunteers
- 152 people
- Sponsor
- The Third Xiangya Hospital of Central South University
Non-squamous Non-small Cell Lung Cancer
Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel
The purpose of this clinical study is to evaluate the tolerability and toxicity of different dose of Anlotinib puls Pemetrexed/Docetaxel in Second-line Treatment of Advanced Gene Negative Non-squamous Non-small Cell Lung Cancer …
- Trial name
- NCT03566576
- Testing
- Anlotinib, Pemetrexed, Docetaxel
- Volunteers
- 18 people
- Sponsor
- Fujian Cancer Hospital